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Having just come from Montreal where I participated in the Meeting of the Parties of 
the Cartagena Biosafety Protocol and then later at BIO005, it is clear that a number of 
issues face plant science and biotechnology. There is much to be said about the impor-
tance of public-sector scientists speaking their minds and stating the facts with regard to 
the issues of applications of agriculture biotechnology. Now is an absolutely appropriate 
time. Last year’s conference—gleaned from leafing through the NABC- proceedings 
volume—reminded us how difficult it is for scientists in the public sector to develop a 
product via agricultural biotechnology. The costs required to take a product from the 
experimental stage to commercialization are overwhelming for scientists in the public 
sector. The regulatory oversight policies that have accompanied this industry have, in my 
opinion, gotten so far out of hand that we in the public sector can no longer effectively 
bring products to market.
How	does	one	capture	trait	value	and	how	does	one	prevent	the	
escape	of	a	trait?
today I will discuss the rationale for controlling the expression of transgenes—including 
the use of gene-switching technologies—that will reduce the transfer of transgenic traits 
and may reduce regulatory concerns of agricultural biotechnology. A description of the 
technology of chemical control of gene expression will be followed by a brief discussion 
of some of the potential issues of concern about the use of gene-expression technology. 
Lastly, I’ll put the technology in the context of the topic of this conference: How does one 
capture trait value and how does one prevent the escape of a trait where it is not wanted, 
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Controlling	gene	expression	for	commercially	valuable	traits	may	
be	necessary	as	a	means	of	capturing	value.
either through theft or through out-crossing, while reducing adventitious presence of a 
GM product in a non-GM crop.
It is important to find ways to continue to innovate while making the products of 
 agricultural biotechnology profitable, if the technology is to reach its potential. My concern 
is that if we don’t find ways to capitalize on the significant investments that have been 
made in the basic plant sciences by federal and non-federal funding sources by developing 
relevant knowledge and potential products, there will eventually be reductions in research 
funding in the public sector. 
There are several benefits of controlling expression of transgenes in plants.
• For basic studies of gene function. Many gene functions are lethal if mis-ex-
pressed and it may be desirable to exert tight control over gene expression.
• to reduce the spread of a genetic trait to a weedy relative or to non-GM varieties 
of the crop plant. Control of trait expression can significantly reduce likelihood of 
adventitious presence of a controlled product and, of course, nonessential release 
to the environment. For example, when considering the use of plants to produce 
a novel food product, an industrial or pharmaceutical material, gene switching 
will limit expression of the materials to plants or plant tissues in which the gene is 
activated. 
• to capture value of the new trait. Controlling gene expression for commercially 
valuable traits may be necessary as a means of capturing value, in particular in 
crops that are inbred, or where seeds can be saved. 
Methods to Control Gene Expression and 
Applications in Biotechnology
The regulation of gene expression is a complex process that requires the coordinated 
activity of proteins and nucleic acids that ultimately determine whether a gene is or is 
not transcribed, and if transcribed, results in production of a protein that produces a 
phenotype. Most of the emphases of studies of gene expression have been on regulation 
of gene transcription, and a number of technical methods are used to affect the control of 
gene expression. First, one can use a promoter that has known regulatory characteristics; 
for example, a promoter that is expressed only in vascular tissues, in the leaf epidermis, 
seed endosperm or embryo, and so on. Or one can mix and match fragments of DNA 
and transcription factors to develop chimeric promoters that have the desired patterns 
and levels of gene expression. 
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In my laboratory we study a promoter that is expressed in plant vascular tissues [a 
promoter from rice tungro bacilliform badnavirus (rtBV)] and two transcription fac-
tors (rfa and rFb). The factors, in conjunction with other co-factors and components 
of rNA polymerase II, are responsible for tissue-specific gene expression of the rtBV 
promoter. The rtBV promoter is expressed only in vascular tissues in transgenic rice, 
Arabidopsis and tobacco plants. However, when genes encoding rFa or rFb are consti-
tutively expressed (using the constitutive 35S promoter) the rtBV promoter was likewise 
expressed constitutively (Petrucelli et	al., 00; Dai  et	al., 00). As a consequence of this 
and other research, we identified the DNA-sequence element to which rFa and other 
transcription regulators bind to govern expression of the promoter (Dai et	al., 00). We 
have used these and other elements to create a regulatable gene-transcription cascade that 
can be “put to work” to control the expression of transgenes in plants, including using 
a chemical gene switch.
The remainder of the discussion will be devoted to describing systems that can be 
used to control expression of genes at will. The challenge with all systems is that none is 
perfect for all applications, and it is important to define the intended application prior 
to making a choice. Some switches are more appropriate than others for experimental use 
and for field use. to date, most research on gene switching has been applied to laboratory 
studies. Nevertheless, the potential applications of gene switching are numerous and it is 
anticipated that a number of commercial applications will be developed. 
Basic Components
The basic components of a good chemical gene-switching system include: () a suitable 
inducer; () a receptor-like protein that binds the ligand; (3) a promoter that is activated 
or repressed as a consequence of binding of ligand to the receptor. Over the last 5 years, 
a number of gene-switching technologies have been developed, including those induced 
by cations, phytohormones, steroid-related molecules, antibiotics, ethanol, herbicide 
safeners, and other organic molecules. Several recent reviews have described the state of 
the science in this topic area (e.g., Padidam	et	al., 003).
A suitable chemically regulated or inducible gene-expression system will have a number 
of characteristics, including: () high specificity of the ligand for the receptor to ensure 
that genes are tightly regulated to be “on” or “off” in the absence of the ligand; () the 
ligand should be readily taken up by the plant and move to all organs and tissues; (3) 
the ligand should elicit a rapid response; () the ligand should be non-toxic to the target 
and non-target organisms; (5) the ligand should be active at low concentrations and have 
a favorable environmental profile; () the ligand should be suitable for convenient ap-
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the Ecr-Methoxyfenozide System
In my laboratory, we have experimented with and adapted a system based on the ecdysone 
receptor (Ecr). These receptors are found in lepidopteran insects that are activated by 
ecdysone, a compound that regulates insect growth. In this system an inactive Ecr recep-
tor remains in the cytoplasm until ecdysone, or a suitable agonist, binds, after which the 
ligand-receptor complex is transported to the nucleus where it binds to the responsive 
DNA-sequence element. Under appropriate conditions, binding of the complex causes 
a change in gene expression. In insects and other animal cells, the system is bi-partite, 
and requires an additional endogenous protein. Padidam et	al. (003) developed a mono-
partite inducible expression system that is appropriate for use in plants and plant cells. 
The chimeric receptor comprises the VP-activator domain from SV0, the gal- DNA 
binding domain, and Ecr (the chimeric receptor is referred to as “VGE”). When the gene 
encoding the chimeric receptor is produced from a promoter that is either constitutive or 
tissue-specific, it remains inactive until ecdysone or a suitable agonist binds and causes the 
complex to activate gene expression by binding to the gal- cis element that is a component 
of the target promoter. Methoxyfenozide is a suitable agonist of ecdysone and a suitable 
ligand in this system. It is proposed that methoxyfenozide causes the formation of a dimer 
with the receptor, which binds to the DNA-binding site on a chimeric gene. The system 
is easy to use and is highly active in Arabidopsis	and other plants. Methoxyfenozide is the 
active ingredient in the insecticide Mimic® (Dow AgroSciences LLC). 
Methoxyfenozide has a suitable safety profile for use as a gene switch in laboratory and 
greenhouse conditions. Furthermore, it does not cause non-specific expression of a high 
number of genes in Arabidopsis (S. Dai, I. Ordiz and r.N. Beachy, unpublished data), an 
indication that the ligand has very little direct effect on the host plant. Furthermore, the 
level of expression of a target gene can be controlled by the concentration of the ligand. 
In other studies, we developed several hundred transgenic Arabidopsis plant lines that 
produce luciferase upon addition of methoxyfenozide. These studies confirmed that, like 
other transgenes, expression of the gene-switch system is controlled by position effects 
and different lines respond to different concentrations of the ligand and exhibit different 
rates of responsiveness (S. Dai, I. Ordiz and r.N. Beachy, unpublished data).
We used the methoxyfenozide gene-switch system to demonstrate that the ligand is 
taken up and systemically distributed in Arabidopsis plants and can induce the expression 
of the transgene in a variety of tissue types. These studies demonstrated that the ligand is 
taken up rapidly when applied to roots, is transmitted throughout the plant and causes 
expression in all cells. We then went on to show that the system can be used to induce 
expression of a gene encoding the coat protein of tMV-Cg tobamovirus, and induce 
coat-protein-mediated resistance against the virus following addition of methoxyfenozide 
(Koo	et	al., 00). In one plant line, the level of accumulation of coat protein exceeded 
the highest level produced by the enhanced 35S promoter. to date we have developed 
more than 750 plant lines using this system and have observed a variety of levels of gene 
induction, from 0-fold to more than ,000-fold following addition of the ligand. 
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Applications of the Gene-Switch System
In an ongoing study, we are evaluating the methoxyfenozide gene-switch system to de-
termine whether or not gene-switching technologies can be used to induce tissue-specific 
expression of genes. For these studies we selected promoters that are known to be expressed 
only in selected plant tissues, and constructed genes with the VGE-coding sequence. 
The gene was co-introduced with a uidA	(encoding GUS) reporter gene that is under 
control of a minimal 35S promoter ligated with the DNA-binding site for recognition 
by the receptor. In these studies the reporter gene was silent in the absence of VGE and 
methoxyfenozide. Although the study is not yet completed, we are encouraged with the 
results and are confident that they will show that the gene-switch system can be used to 
restrict gene expression to specific tissues after addition of the ligand.
How might one use a gene-switching system? One of the experiments in progress is to 
develop a system to control multiple genes with application of the ligand. If successful, 
we will use the system to activate expression of genes that cause the repression/suppression 
of a gene in one or more metabolic pathways while activating other genes in the same 
or other pathways. If successful, this will make it possible to substantially alter primary 
and/or secondary metabolism in plants. We do not yet know the limits of the system, but 
are confident that it is sufficiently robust to make significant changes in the metabolism 
as well as growth and development of the target plant.
the Next Generation 
The next generation of chemical gene switches will likely be substantially different and 
better than current systems. There will be improved receptors that eliminate proteins of 
animal origin, and receptors that provide active repression as well as activation of gene 
expression. We also anticipate that a variety of ligand:receptor pairs will be developed, and 
that future developments will create plants that will respond to multiple gene switches.
rheoGene Co. (Philadelphia, PA) has developed several different receptor:ligand pairs 
that function in animal cells. It is anticipated that some of these will function in plants 
either in a two-protein or one-protein gene-switch system. This may make it possible to 
use one ligand to turn on a target gene and a second ligand to turn the gene off. Such 
flexibility in the system would have other uses: for example, company A might want to 
use a unique receptor:ligand pair while company B will want another receptor ligand 
pair, and so forth.
It is likely that there will be additional opportunities for ligand-receptor develop-
ment with a variety of different biological characteristics. The challenge is, of course, to 
identify gene-switching systems that are safe for the environment, the plant, and for the 
final product. And, if a chemical ligand is to be released to the environment, it must pass 
The	next	generation	of	chemical	gene	switches	will	likely	be	
substantially	different	and	better	than	current	systems.
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standard EPA toxicology tests. For this reason, scientists anticipate that early adoption 
of chemical gene-switching systems will involve ligands that have been approved as safe 
or that can be thus approved with modest investment.
regulatory Considerations
The development of safe and reliable gene switches that are used commercially will rely 
on new applications of existing chemistry or on new chemistry; regulatory approvals 
will be required either for new use or for new chemicals that will be used. Furthermore, 
one must ensure that there is strict on/off control of gene expression; leakiness of gene 
expression will not be acceptable. This is essential if one expects the public to agree to 
selected types of agricultural biotechnology. 
In order for chemical gene switching to be widely used, it will be necessary for regulatory 
agencies to adapt and undergo certain types of change. At the present time, the agencies 
regulate transgenic organisms on the basis of the presence or absence of transgene DNA 
and/or the presence of the gene product. Many scientists agree that the most important 
criterion for phenotype is not the presence or absence of a transgene per	se, but whether or 
not the product of gene expression (i.e., the rNA or a protein product) and the resulting 
phenotype are produced. Thus, the manner in which products are subjected to regulatory 
control will need to be established. 
Public Discussion
As with any new technology, it is important to engage the public, both academic and 
non-academic, in discussions related to issues that may have impact on regulatory 
structures, on environmental safety, and with regard to possible ethical issues that may 
arise. It’s perhaps more important now than it was in following the first breakthroughs 
in agricultural biotechnology in the 980s. In January, 005, we held a workshop at 
the Danforth to discuss chemical gene switching with ethicists and environmentalists 
to help us better understand the challenges that might be faced in bringing forward a 
viable gene-control system. I think that engaging the public and non-scientists in such 
discussions is important for all of us.
There is concern amongst some parties that limitations on trait expression will 
limit access of some technologies to those farmer/producers that can afford to pay high 
technology fees. It is considered likely that gene-switching systems will be first used on 
crops that will produce high-value materials; uses on field crops or other food crops are 
much less likely, except to restrict trait flow to non-GM crops. It is highly unlikely that 





are produced by small-scale, economically disadvantaged farmers. Unlike the so-called 
sterile seed technologies, gene switching as outlined here will not be applied to restrict 
seed germination per	se.
I am convinced that we have an opportunity to make outstanding strides forward in 
biotechnology, but am increasingly concerned that much of the potential will not be 
realized unless we learn to deal with some of the issues that can be addressed by gene 
switching. Whether or not gene-switching technologies emerge as a tool to bring new 
agricultural biotechnologies to the public marketplace depends on many factors. Chal-
lenges notwithstanding, the potential of the technology is high and I am confident that 
it will be an important component of agricultural biotechnology.
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